COMUNICADO: ALIMTA® Label Update Approved by European Commission to Reflect Significant Overall Survival Benefits for Specific Lung

 

COMUNICADO: ALIMTA® Label Update Approved by European Commission to Reflect Significant Overall Survival Benefits for Specific Lung

Actualizado 30/10/2012 14:01:42 CET

[i] Paz-Ares L. G., et al. PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC).J Clin Oncol 29: 2011 (suppl; abstr CRA7510).

[ii] World Health Organization International Agency for Research in Cancer, GLOBOCAN 2008, Section of Cancer Information, http://globocan.iarc.fr/factsheets/cancers/lung.asp [http://globocan.iarc.fr/factsheets/cancers/lung.asp], (Accessed June 20, 2012).

[iii] American Cancer Society, "What Is Non-Small Cell Lung Cancer?," February 17, 2012, American Cancer Society, http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer [http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer], (Accessed June 20, 2012).

[iv] American Cancer Society, "What Is Non-Small Cell Lung Cancer?," February 17, 2012, American Cancer Society, http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer [http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer], (Accessed June 20, 2012).

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO [http://photos.prnewswire.com/prnh/20031219/LLYLOGO] )

CONTACT: Refer to: +1-317-651-4017 (Carla Cox, Lilly), +1-317-473-4368(mobile), cox_carla_l@lilly.com

Web site: http://www.LillyOncology.com/

Mejora la comunicación de tu empresa con Europa Press Comunicación

Mejora la comunicación de tu empresa con Europa Press Comunicación

Esta web utiliza cookies propias y de terceros para analizar su navegación y ofrecerle un servicio más personalizado y publicidad acorde a sus intereses. Continuar navegando implica la aceptación de nuestra política de cookies -
Uso de cookies